Our journal Exploration of Targeted Anti-tumor Therapy is pleased to announce the winners of the Highly Cited Paper Award 2024. This year, the award is presented to two outstanding articles from two Special Issues titled "The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor" and "Theranostic Frontiers in Neuro-Oncology". We extend our heartfelt congratulations to the awardees and express our gratitude to all contributors for their dedication to advancing tumor research.
Winning Articles
Authors: Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte , Giulia Martini, Teresa Troiani, Stefania Napolitano *
DOI: https://doi.org/10.37349/etat.2023.00125
● Liquid biopsy and glioblastoma
Authors: Robert H. Eibl *, Markus Schneemann
DOI: https://doi.org/10.37349/etat.2023.00121
Criteria for Selection and Award
The articles are published in 2023-2024.
Both regular and Special Issue submissions are considered.
Citations are counted according to the Web of Science (WOS) in 2024.
Rewards
The Author team: a monetary reward of 300-1000 USD; the certificate of Highly Cited Paper Award; one-time 100% APC waiver.
The corresponding Guest Editor team: a monetary reward of 100-300 USD.
Looking Ahead
The Highly Cited Paper Award will continue in 2025, celebrating the exceptional achievements of authors and their impactful research published in our journal. We look forward to recognizing more groundbreaking work in the years to come.